Generics Global Industry Almanac 2013-2022
Summary
Global Generics industry profile provides top-line qualitative and quantitative summary information including: market size (value and volume 2013-17, and forecast to 2022). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
Key Questions Answered:
- What was the size of the global generics market by value in 2017?
- What will be the size of the global generics market in 2022?
- What factors are affecting the strength of competition in the global generics market?
- How has the market performed over the last five years?
- How large is the global generics market in relation to its regional counterparts?
Scope
Essential resource for top-line data and analysis covering the global generics market. Includes market size data, textual and graphical analysis of market growth trends and leading companies.
- For the purposes of this profile, a generic drug is defined as a copy of an ethical (prescription) drug formerly protected by patents that have now expired. Both unbranded generics and all branded generics are included. However, off-patent drugs that continue to be offered by the original manufacturer under the original name, and which form part of the 'generic-eligible' market, are not included.
- The market value is evaluated at ex-factory prices.
- Market volume is quantified here as the percentage of the total ethical pharmaceutical market volume in a country or region which is accounted for by generic drugs. It is therefore a generics penetration rate measure, not an absolute measure of market volume.
- Regional volumes are calculated as weighted averages of countries which make up the region in question where volume data exists.
- Note that any volumes of "1" (one) or 100% are due to rounding as MarketLine does not believe that generics will ever fully represent 100% of the medicinal market in any country or region.
- All currency conversions were calculated at constant average annual 2017 exchange rates.
- The global generics market had total revenues of $307.6bn in 2017, representing a compound annual growth rate (CAGR) of 8.2% between 2013 and 2017.
- Market consumption volume increased with a CAGR of 1.9% between 2013 and 2017, to reach a total of 70.2% in 2017.
- The US is the largest market in the world; it made up 33.5% of the global value in 2017. Other large markets include China, Japan, Germany, and India.
Reasons to buy
- Save time carrying out entry-level research by identifying the size, growth, and leading players in the global generics market
- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the global generics market
- Leading company profiles reveal details of key generics market players' global operations and financial performance
- Add weight to presentations and pitches by understanding the future growth prospects of the global generics market with five year forecasts by both value and volume
Generics Global Industry Almanac 2013-2022
Table of Contents
EXECUTIVE SUMMARY 2
Market value 2
Market value forecast 2
Market volume 2
Market volume forecast 2
Geography segmentation 2
Introduction 32
What is this report about? 32
Who is the target reader? 32
How to use this report 32
Definitions 32
Global Generics 33
Market Overview 33
Market Data 35
Market Segmentation 37
Market outlook 38
Five forces analysis 40
Generics in Asia-Pacific 46
Market Overview 46
Market Data 48
Market Segmentation 50
Market outlook 51
Five forces analysis 53
Generics in Europe 59
Market Overview 59
Market Data 61
Market Segmentation 63
Market outlook 64
Five forces analysis 66
Generics in France 72
Market Overview 72
Market Data 73
Market Segmentation 75
Market outlook 76
Five forces analysis 78
Macroeconomic indicators 84
Generics in Germany 86
Market Overview 86
Market Data 87
Market Segmentation 89
Market outlook 90
Five forces analysis 92
Macroeconomic indicators 98
Generics in Australia 100
Market Overview 100
Market Data 101
Market Segmentation 103
Market outlook 104
Five forces analysis 106
Macroeconomic indicators 112
Generics in Brazil 114
Market Overview 114
Market Data 115
Market Segmentation 117
Market outlook 118
Five forces analysis 120
Macroeconomic indicators 126
Generics in Canada 128
Market Overview 128
Market Data 129
Market Segmentation 131
Market outlook 132
Five forces analysis 134
Macroeconomic indicators 141
Generics in China 143
Market Overview 143
Market Data 144
Market Segmentation 146
Market outlook 147
Five forces analysis 149
Macroeconomic indicators 156
Generics in India 158
Market Overview 158
Market Data 159
Market Segmentation 161
Market outlook 162
Five forces analysis 164
Macroeconomic indicators 170
Generics in Indonesia 172
Market Overview 172
Market Data 173
Market Segmentation 175
Market outlook 176
Five forces analysis 178
Macroeconomic indicators 184
Generics in Italy 186
Market Overview 186
Market Data 187
Market Segmentation 189
Market outlook 190
Five forces analysis 192
Macroeconomic indicators 198
Generics in Japan 200
Market Overview 200
Market Data 201
Market Segmentation 203
Market outlook 204
Five forces analysis 206
Macroeconomic indicators 212
Generics in Mexico 214
Market Overview 214
Market Data 215
Market Segmentation 217
Market outlook 218
Five forces analysis 220
Macroeconomic indicators 226
Generics in The Netherlands 228
Market Overview 228
Market Data 229
Market Segmentation 231
Market outlook 232
Five forces analysis 234
Macroeconomic indicators 240
Generics in North America 242
Market Overview 242
Market Data 243
Market Segmentation 245
Market outlook 246
Five forces analysis 248
Generics in Russia 255
Market Overview 255
Market Data 256
Market Segmentation 258
Market outlook 259
Five forces analysis 261
Macroeconomic indicators 267
Generics in Scandinavia 269
Market Overview 269
Market Data 270
Market Segmentation 272
Market outlook 273
Five forces analysis 275
Generics in Singapore 281
Market Overview 281
Market Data 282
Market Segmentation 284
Market outlook 285
Five forces analysis 287
Macroeconomic indicators 293
Generics in South Africa 295
Market Overview 295
Market Data 296
Market Segmentation 298
Market outlook 299
Five forces analysis 301
Macroeconomic indicators 307
Generics in South Korea 309
Market Overview 309
Market Data 310
Market Segmentation 312
Market outlook 313
Five forces analysis 315
Macroeconomic indicators 321
Generics in Spain 323
Market Overview 323
Market Data 324
Market Segmentation 326
Market outlook 327
Five forces analysis 329
Macroeconomic indicators 335
Generics in Turkey 337
Market Overview 337
Market Data 338
Market Segmentation 340
Market outlook 341
Five forces analysis 343
Macroeconomic indicators 349
Generics in The United Kingdom 351
Market Overview 351
Market Data 352
Market Segmentation 354
Market outlook 355
Five forces analysis 357
Macroeconomic indicators 364
Generics in The United States 366
Market Overview 366
Market Data 367
Market Segmentation 369
Market outlook 370
Five forces analysis 372
Macroeconomic indicators 378
Company Profiles 380
Leading Companies 380
Appendix 457
Methodology 457
About MarketLine 458
List of Tables
Table 1: Global generics market value: $ billion, 2013-17
Table 2: Global generics market volume: % of total pharma, 2013-17
Table 3: Global generics market geography segmentation: $ billion, 2017
Table 4: Global generics market value forecast: $ billion, 2017-22
Table 5: Global generics market volume forecast: % of total pharma, 2017-22
Table 6: Asia-Pacific generics market value: $ billion, 2013-17
Table 7: Asia-Pacific generics market volume: % of total pharma, 2013-17
Table 8: Asia-Pacific generics market geography segmentation: $ billion, 2017
Table 9: Asia-Pacific generics market value forecast: $ billion, 2017-22
Table 10: Asia-Pacific generics market volume forecast: % of total pharma, 2017-22
Table 11: Europe generics market value: $ billion, 2013-17
Table 12: Europe generics market volume: % of total pharma, 2013-17
Table 13: Europe generics market geography segmentation: $ billion, 2017
Table 14: Europe generics market value forecast: $ billion, 2017-22
Table 15: Europe generics market volume forecast: % of total pharma, 2017-22
Table 16: France generics market value: $ million, 2013-17
Table 17: France generics market volume: % of total pharma, 2013-17
Table 18: France generics market geography segmentation: $ million, 2017
Table 19: France generics market value forecast: $ million, 2017-22
Table 20: France generics market volume forecast: % of total pharma, 2017-22
Table 21: France size of population (million), 2013-17
Table 22: France gdp (constant 2005 prices, $ billion), 2013-17
Table 23: France gdp (current prices, $ billion), 2013-17
Table 24: France inflation, 2013-17
Table 25: France consumer price index (absolute), 2013-17
Table 26: France exchange rate, 2013-17
Table 27: Germany generics market value: $ million, 2013-17
Table 28: Germany generics market volume: % of total pharma, 2013-17
Table 29: Germany generics market geography segmentation: $ million, 2017
Table 30: Germany generics market value forecast: $ million, 2017-22
Table 31: Germany generics market volume forecast: % of total pharma, 2017-22
Table 32: Germany size of population (million), 2013-17
Table 33: Germany gdp (constant 2005 prices, $ billion), 2013-17
Table 34: Germany gdp (current prices, $ billion), 2013-17
Table 35: Germany inflation, 2013-17
Table 36: Germany consumer price index (absolute), 2013-17
Table 37: Germany exchange rate, 2013-17
Table 38: Australia generics market value: $ million, 2013-17
Table 39: Australia generics market volume: % of total pharma, 2013-17
Table 40: Australia generics market geography segmentation: $ million, 2017
Table 41: Australia generics market value forecast: $ million, 2017-22
Table 42: Australia generics market volume forecast: % of total pharma, 2017-22
Table 43: Australia size of population (million), 2013-17
Table 44: Australia gdp (constant 2005 prices, $ billion), 2013-17
Table 45: Australia gdp (current prices, $ billion), 2013-17
Table 46: Australia inflation, 2013-17
Table 47: Australia consumer price index (absolute), 2013-17
Table 48: Australia exchange rate, 2013-17
Table 49: Brazil generics market value: $ million, 2013-17
Table 50: Brazil generics market volume: % of total pharma, 2013-17
Table 51: Brazil generics market geography segmentation: $ million, 2017
Table 52: Brazil generics market value forecast: $ million, 2017-22
Table 53: Brazil generics market volume forecast: % of total pharma, 2017-22
Table 54: Brazil size of population (million), 2013-17
List of Figures
Figure 1: Global generics market value: $ billion, 2013-17
Figure 2: Global generics market volume: % of total pharma, 2013-17
Figure 3: Global generics market geography segmentation: % share, by value, 2017
Figure 4: Global generics market value forecast: $ billion, 2017-22
Figure 5: Global generics market volume forecast: % of total pharma, 2017-22
Figure 6: Forces driving competition in the global generics market, 2017
Figure 7: Drivers of buyer power in the global generics market, 2017
Figure 8: Drivers of supplier power in the global generics market, 2017
Figure 9: Factors influencing the likelihood of new entrants in the global generics market, 2017
Figure 10: Factors influencing the threat of substitutes in the global generics market, 2017
Figure 11: Drivers of degree of rivalry in the global generics market, 2017
Figure 12: Asia-Pacific generics market value: $ billion, 2013-17
Figure 13: Asia-Pacific generics market volume: % of total pharma, 2013-17
Figure 14: Asia-Pacific generics market geography segmentation: % share, by value, 2017
Figure 15: Asia-Pacific generics market value forecast: $ billion, 2017-22
Figure 16: Asia-Pacific generics market volume forecast: % of total pharma, 2017-22
Figure 17: Forces driving competition in the generics market in Asia-Pacific, 2017
Figure 18: Drivers of buyer power in the generics market in Asia-Pacific, 2017
Figure 19: Drivers of supplier power in the generics market in Asia-Pacific, 2017
Figure 20: Factors influencing the likelihood of new entrants in the generics market in Asia-Pacific, 2017
Figure 21: Factors influencing the threat of substitutes in the generics market in Asia-Pacific, 2017
Figure 22: Drivers of degree of rivalry in the generics market in Asia-Pacific, 2017
Figure 23: Europe generics market value: $ billion, 2013-17
Figure 24: Europe generics market volume: % of total pharma, 2013-17
Figure 25: Europe generics market geography segmentation: % share, by value, 2017
Figure 26: Europe generics market value forecast: $ billion, 2017-22
Figure 27: Europe generics market volume forecast: % of total pharma, 2017-22
Figure 28: Forces driving competition in the generics market in Europe, 2017
Figure 29: Drivers of buyer power in the generics market in Europe, 2017
Figure 30: Drivers of supplier power in the generics market in Europe, 2017
Figure 31: Factors influencing the likelihood of new entrants in the generics market in Europe, 2017
Figure 32: Factors influencing the threat of substitutes in the generics market in Europe, 2017
Figure 33: Drivers of degree of rivalry in the generics market in Europe, 2017
Figure 34: France generics market value: $ million, 2013-17
Figure 35: France generics market volume: % of total pharma, 2013-17
Figure 36: France generics market geography segmentation: % share, by value, 2017
Figure 37: France generics market value forecast: $ million, 2017-22
Figure 38: France generics market volume forecast: % of total pharma, 2017-22
Figure 39: Forces driving competition in the generics market in France, 2017
Figure 40: Drivers of buyer power in the generics market in France, 2017
Figure 41: Drivers of supplier power in the generics market in France, 2017
Figure 42: Factors influencing the likelihood of new entrants in the generics market in France, 2017
Figure 43: Factors influencing the threat of substitutes in the generics market in France, 2017
Figure 44: Drivers of degree of rivalry in the generics market in France, 2017
Figure 45: Germany generics market value: $ million, 2013-17
Figure 46: Germany generics market volume: % of total pharma, 2013-17
Figure 47: Germany generics market geography segmentation: % share, by value, 2017
Figure 48: Germany generics market value forecast: $ million, 2017-22
Figure 49: Germany generics market volume forecast: % of total pharma, 2017-22
Figure 50: Forces driving competition in the generics market in Germany, 2017
Figure 51: Drivers of buyer power in the generics market in Germany, 2017
Figure 52: Drivers of supplier power in the generics market in Germany, 2017
Figure 53: Factors influencing the likelihood of new entrants in the generics market in Germany, 2017
Figure 54: Factors influencing the threat of substitutes in the generics market in Germany, 2017
Figure 55: Drivers of degree of rivalry in the generics market in Germany, 2017
Figure 56: Australia generics market value: $ million, 2013-17
Figure 57: Australia generics market volume: % of total pharma, 2013-17
Figure 58: Australia generics market geography segmentation: % share, by value, 2017
Global Histone Deacetylase (HDAC) Inhibitors Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 87
The global Histone Deacetylase (HDAC) Inhibitors market was valued at US$ 615.2 million in 2023 and is anticipated to reach US$ 1223.2 million by 2030, witnessing a CAGR of 8.8% during The forecast period 2024-2030.
North American market for Histone Deacetylase (HDAC) Inhibitors is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Histone Deacetylase (HDAC) Inhibitor......
Global Esomeprazole Magnesium Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 74
The global Esomeprazole Magnesium market was valued at US$ 5287 million in 2023 and is anticipated to reach US$ 9451.5 million by 2030, witnessing a CAGR of 8.3% during The forecast period 2024-2030.
North American market for Esomeprazole Magnesium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Esomeprazole Magnesium is estimated to increase from $ million in 2......
Global Combination Therapy Drug Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 86
The global Combination Therapy Drug market was valued at US$ 105 million in 2023 and is anticipated to reach US$ 166.7 million by 2030, witnessing a CAGR of 4.1% during The forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is......
Global Axitinib Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 68
The global Axitinib market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
North American market for Axitinib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Axitinib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The......
Global Lyme Disease Vaccine Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 70
The lyme disease vaccine can reduce lyme disease incidence, reduce symptoms and reduce mortality. Lyme disease is a tick-borne infection of spirochete, a natural disease caused by borrelia burgdorferi.
The global Lyme Disease Vaccine market was valued at US$ 257 million in 2023 and is anticipated to reach US$ 763 million by 2030, witnessing a CAGR of 8.8% during The forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at......
Global Transdermal Absorption Patch Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 85
The global Transdermal Absorption Patch market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
North American market for Transdermal Absorption Patch is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Transdermal Absorption Patch is estimated to increase from $ million i......
Global Ketoprofen Patches Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 78
Ketoprofen patch, indications for The treatment of symptoms caused by The following diseases: rheumatoid arthritis and rheumatoid arthritis
The global Ketoprofen Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
North American market for Ketoprofen Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast per......
Global Methyl Salicylate Patches Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 82
The global Methyl Salicylate Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
North American market for Methyl Salicylate Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Methyl Salicylate Patches is estimated to increase from $ million in 2023 to......
Global Diclofenac Patches Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 94
The global Diclofenac Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
North American market for Diclofenac Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Diclofenac Patches is estimated to increase from $ million in 2023 to reach $ million by 2......
SERVICES
Value for Money
We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
Ever Growing Inventory
Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
One Stop Solution
Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
Dedicated Client Engagement
Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
Saving Time and Efforts
Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
Payment Flexibility
Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
Post-Purchase Research Support
Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements.
Subscription Offers & Packages (Get in touch with us for more details -
[email protected] / +1 888 391 5441 )
- Ad Hoc
-
- Pay - as - you - go / Bucket Subscriptions
- Fixed Cost for #of reports
- Customize / Personalize as per your needs
